Medication info
Noval Tan Tablet 5/80 mg

Noval Tan Tablet 5/80 mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›80mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Kyungbo Pharmaceutical Co., Ltd.
Appearance
Dark yellow round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201308589 · Approved 2013.07.31 · Insurance code 665001770

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take this medicine at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction/cholestasis. Patients aged 65 years or older: Exercise caution when increasing the dose.
Child dose
This medicine is not recommended for children under 18 years of age because its safety and efficacy have not been established.

Ingredients

Manufacturer
Kyungbo Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy of amlodipine or valsartan.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take this medicine at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction/cholestasis. Patients aged 65 years or older: Exercise caution when increasing the dose.

Child dose

This medicine is not recommended for children under 18 years of age because its safety and efficacy have not been established.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Patients who have allergies to this medication or similar drugs, pregnant or breastfeeding women, patients with severe kidney or liver dysfunction, and those with certain heart diseases should not take this medication. Patients with reduced body sodium or fluid may experience excessively low blood pressure when taking this medication. Therefore, their condition should be carefully checked before use, and it should be taken under medical supervision. Patients with high potassium levels or those taking other medications that can increase potassium levels should have their potassium levels monitored frequently. Patients with vascular issues in the kidneys or kidney transplant patients, those with a history of angioedema, patients with heart failure, and those recovering from myocardial infarction need to take special precautions when using this medication. While taking this medication, side effects such as dizziness, fatigue, headache, edema, hypotension, skin rash, etc., may occur; if any unusual symptoms arise, consult a doctor. Caution should be exercised as dizziness or fatigue may occur while driving or operating machinery. This medication may interact with other blood pressure medications, potassium supplements, diuretics, and non-steroidal anti-inflammatory drugs (NSAIDs), so be sure to inform your doctor about any other medications you are taking. Women who are pregnant or planning to become pregnant should avoid using this medication, and breastfeeding women are also advised not to use this medication. The safety and efficacy of this medication in children under 18 years of age have not been adequately established, so it is not recommended for use in this age group. Overdose can result in severe hypotension or heart issues, so care should be taken not to exceed the recommended dosage. It is important to regularly check blood pressure, kidney function, and electrolyte levels to confirm any abnormal findings during the use of this medication.

Side effects

nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, xerostomia, rash, erythema, hyperhidrosis, pruritus, arthralgia, low back pain, arthritis, muscle spasms, lethargy, increased urinary frequency, polyuria, erectile dysfunction, edema, localized edema, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, hyperkalemia, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory decline, taste disturbance, peripheral neuropathy, muscle hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reactions, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disorders, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, neurogenic hyperalgesia, sensory decline, Stevens-Johnson syndrome, dizziness, fatigue, rapid blood pressure drop, symptomatic hypotension, increased blood urea nitrogen, elevated serum creatinine, increased BUN, abdominal pain, nausea, vomiting, diarrhea, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to prevent exposure to air or moisture. It is recommended to keep it at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Dark yellow round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.